Highbridge Capital Management
STLNW icon

Highbridge Capital Management’s Starling Oncology Warrant STLNW Stock Holding History

Highbridge Capital Management’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– – – 404
2023
Q1 		– Hold
0
– – – 386
2022
Q4 		– Hold
0
– – – 357
2022
Q3 		– Hold
0
– – – 370
2022
Q2 		– Hold
0
– – – 377
2022
Q1 		– Hold
0
– – – 351
2021
Q4 		– Hold
0
– – – 403
2021
Q3 		– Hold
0
– – – 266

Other funds holding STLNW

LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $64.4B AUM 36.06% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
Cowen and Company
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return